{"status":"success","data":{"title":"Hyperkalemia","slug":"hyperkalemia","tags":["insulin","albuterol","furosemide","sodium bicarbonate","Kayexalate","calcium gluconate"],"collection":["endocrine","metabolic","critical care"],"content":"\n# Hyperkalemia\n\n**Potassium regulation**\n\n-   **Internal K shift:** modulated by insulin, catecholamines, acid-base status\n-   **Total body K elimination:** By kidney(95%) and gut (5%)\n\n## Adverse effects of hyperkalemia\n\n-   **Cardiac:** Peaked T, wide QRS, loss of P wave, sine wave; although V fib may be first cardiac manifestation.\n-   **Neuromuscular:** Paresthesias,weakness\n-   **Metabolic:** Mild hyperchloremic metabolic acidosis\n\n## Treatment of hyperkalemia\n\n**Cardiac membrane stabilization **\n-   **Calcium:** Reduces threshold potential in myocytes; check to be sure not on digoxin\n-   **Hypertonic saline:** Only for severe hyponatremia in setting of hyperkalemia\n\n **K redistribution**\n-   **Insulin:** Drives K intracellularly and drops serum K level by 0.6 mmol/L\n-   **Beta-agonist:** Drives K intracellularly and 10 mg albuterol drops serum K level by 0.6 mmol/L(20 mg --&gt; K drops by 1 mmol/L);effective in only 60% of patients\n\n** K elimination via kidney/gut**\n-   **Bicarbonate:** drives K out at distal nephron; best as infusion x 4-6 hrs\n-   **Loop diuretic**\n-   **Exchange resin** (sodium polystyrene sulfonate): case reports of colonic necrosis;constipating med and so combined with sorbitol; minimal benefit. \n\n\n<table>\n  <tr>\n    <th>Agent</th>\n    <th>Dose</th>\n    <th>Onset</th>\n    <th>Duration</th>\n    <th>Complication</th>\n  </tr>\n  <tr>\n    <td colspan=\"5\">**Membrane Stabilization**</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Ca gluconate 10%</span></td>\n    <td>10 mL over 10 min</td>\n    <td>immediate</td>\n    <td>30-60min</td>\n    <td>hypercalcemia</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Hypertonic 3% NaCl</span></td>\n    <td>50cc IV push</td>\n    <td>immediate</td>\n    <td>unknown</td>\n    <td>volume overload, hypertonicity</td>\n  </tr>\n  <tr>\n    <td colspan=\"5\">**Redistribution**</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Insulin</span></td>\n    <td>10 units IVP with D50W</td>\n    <td>20 min</td>\n    <td>4-6 hr</td>\n    <td>hypoglycemia</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Albuterol nebulized</span></td>\n    <td>20mg/4cc over 10 min</td>\n    <td>30 min</td>\n    <td>2 hrs</td>\n    <td>tachycardia</td>\n  </tr>\n  <tr>\n    <td colspan=\"5\">**Elimination**</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Loop diuretic</span></td>\n    <td>furosemide 40-80 mg IV</td>\n    <td>15 min</td>\n    <td>2-3 hr</td>\n    <td>volume depletion</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Sodium bicarbonate</span></td>\n    <td>150 mmol/L IV</td>\n    <td>hours</td>\n    <td>infusion</td>\n    <td>metabolic alkalosis, volume overload</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Kayexalate</span></td>\n    <td>150-30 g</td>\n    <td>>2 hrs</td>\n    <td>4-6 hr</td>\n    <td>variable efficacy</td>\n  </tr>\n  <tr>\n    <td><span class=\"drug\">Hemodialysis</span></td>\n    <td></td>\n    <td>immediate</td>\n    <td>3 hrs</td>\n    <td>arrhythmias</td>\n  </tr>\n</table>\n\n\n## References\n\n-   [Weisberg LS. Management of severe hyperkalemia. Crit Care Med. 2008; 36:3246-51.](https://www.ncbi.nlm.nih.gov/pubmed/?term=18936701)\n"}}